- Home
- PEBK vs ALEC Comparison
PEBK vs ALEC Comparison
Compare PEBK & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PEBK
- ALEC
- Stock Information
- Founded
- PEBK 1912
- ALEC 2013
- Country
- PEBK United States
- ALEC United States
- Employees
- PEBK N/A
- ALEC N/A
- Industry
- PEBK Major Banks
- ALEC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PEBK Finance
- ALEC Health Care
- Exchange
- PEBK Nasdaq
- ALEC Nasdaq
- Market Cap
- PEBK 145.9M
- ALEC 124.0M
- IPO Year
- PEBK N/A
- ALEC 2019
- Fundamental
- Price
- PEBK $29.83
- ALEC $1.63
- Analyst Decision
- PEBK
- ALEC Buy
- Analyst Count
- PEBK 0
- ALEC 7
- Target Price
- PEBK N/A
- ALEC $4.70
- AVG Volume (30 Days)
- PEBK 12.5K
- ALEC 541.7K
- Earning Date
- PEBK 07-21-2025
- ALEC 08-06-2025
- Dividend Yield
- PEBK 3.22%
- ALEC N/A
- EPS Growth
- PEBK 4.04
- ALEC N/A
- EPS
- PEBK 3.05
- ALEC N/A
- Revenue
- PEBK $83,033,000.00
- ALEC $88,339,000.00
- Revenue This Year
- PEBK N/A
- ALEC N/A
- Revenue Next Year
- PEBK N/A
- ALEC $319.82
- P/E Ratio
- PEBK $9.81
- ALEC N/A
- Revenue Growth
- PEBK 7.01
- ALEC N/A
- 52 Week Low
- PEBK $23.74
- ALEC $0.87
- 52 Week High
- PEBK $33.31
- ALEC $6.78
- Technical
- Relative Strength Index (RSI)
- PEBK 56.07
- ALEC 57.56
- Support Level
- PEBK $29.14
- ALEC $1.41
- Resistance Level
- PEBK $31.74
- ALEC $1.75
- Average True Range (ATR)
- PEBK 1.06
- ALEC 0.12
- MACD
- PEBK 0.14
- ALEC 0.01
- Stochastic Oscillator
- PEBK 56.79
- ALEC 67.90
About PEBK Peoples Bancorp of North Carolina Inc.
Peoples Bancorp of North Carolina Inc is a bank holding company. It is a state-chartered commercial bank serving Lincolnton, Newton, Denver, Catawba, Conover, Maiden, Claremont, Hiddenite, Hickory, Charlotte, Cornelius, Raleigh and Cary, North Carolina. It has a diversified loan portfolio with no foreign loans and few agricultural loans. The company's main source of income is dividends declared and paid by the Bank on its capital stock.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.